| Dr William E Johnson, PHD | |
|
1100 N College Ave, Fayetteville, AR 72703-1944 | |
| (479) 444-5048 | |
| (479) 444-5039 |
| Full Name | Dr William E Johnson |
|---|---|
| Gender | Male |
| Speciality | Psychologist - Clinical |
| Location | 1100 N College Ave, Fayetteville, Arkansas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1770507410 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103TC0700X | Psychologist - Clinical | 77-15P (Arkansas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr William E Johnson, PHD 1100 N College Ave, Fayetteville, AR 72703-1944 Ph: (479) 444-5048 | Dr William E Johnson, PHD 1100 N College Ave, Fayetteville, AR 72703-1944 Ph: (479) 444-5048 |
News Archive
Northrop Grumman Corporation has begun deliveries of critical assay technology to the U.S. Department of Homeland Security as part of the company's BioWatch Gen-3 contract to develop a new generation of biological detectors for homeland defense applications.
From pill-sized cameras to radioactive compounds that let doctors "see" inside a patient's brain, Cleveland Clinic's Top 10 Medical Innovations for 2011 showcases new techniques, therapies and approaches to treating a host of diseases.
According to an Australian Financial Review report the major pharmaceutical companies have agreed to reduce the Australian government's medicine bill by AUD $2 billion over the next four years only if they are assured of price modifications in future. The details of the agreement are to be revealed next week and experts believe it will reduce the burden on the federal budget which is still considering the source of funds to pay for its health reform package.
Watson Pharmaceuticals, Inc. and Natco Pharma Limited today confirmed an exclusive, U.S. development and license agreement, to develop and commercialize lenalidomide 5, 10, 15 and 25 mg tablets. The companies also confirmed that Natco has filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market its lenalidomide 5, 10, 15 and 25 mg product. Natco's lenalidomide tablets are generic versions of Celgene's Revlimid ® Tablets.
Alzheimer's Research UK, the UK's leading dementia research charity, is backing a call for governments worldwide to develop and implement action plans for tackling dementia.
› Verified 7 days ago
Mr. Clark Robert Thompson, MA Psychologist Medicare: Not Enrolled in Medicare Practice Location: 86 W Sunbridge Dr, Fayetteville, AR 72703 Phone: 479-435-6360 | |
Dr. Janissa D Jackson, PHD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1 W Sunbridge Dr, Fayetteville, AR 72703 Phone: 479-443-5575 Fax: 479-443-9554 | |
Dr. Thomas T. Lawson, PH.D Psychologist Medicare: Not Enrolled in Medicare Practice Location: 118 E Sunbridge Dr, Fayetteville, AR 72703 Phone: 479-444-1400 Fax: 479-444-1422 | |
Russell T House, LPE Psychologist Medicare: Not Enrolled in Medicare Practice Location: 60 W Sunbridge Dr, Fayetteville, AR 72703 Phone: 479-695-1240 Fax: 479-750-4843 | |
Dr. Rosalyn D Davis, PHD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 525 N Garland Ave, Pat Walker Health Center Room 255, Fayetteville, AR 72701 Phone: 479-575-5276 | |
Dr. Lissette Vanessa Valenzuela, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 525 N Garland Ave, Fayetteville, AR 72701 Phone: 479-575-5276 | |
Dr. Vickie L. West, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 179 N Church Ave Ste 201, Fayetteville, AR 72701 Phone: 479-521-4909 |